# Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency

> **NCT00630487** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 9 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Placebo
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT00630487
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2013-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630487, "Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00630487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*